MedTrace Logo

A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing

NCT01039467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

The COMPARE-Adapta study is a randomized, multi-center, prospective study conducted in China. The purpose of the study is to compare the ability of Search AV™+ and Managed Ventricular Pacing® (MVP®) to reduce ventricular pacing in dual chamber pacemaker-indicated patients. The COMPARE-Adapta study will also observe atrial fibrillation (AF) burden as demonstrated by Cardiac Compass® and the clinical profile Adapta® pacemaker patients.

Conditions

  • Bradycardia

Interventions

DEVICE

Medtronic Adapta Dual Chamber Pacemaker

Medtronic Adapta Dual Chamber Pacemaker

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Shu Zhang, PhD · Chinese Academy of Medical Sciences, Fuwai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01039467 on ClinicalTrials.gov